These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27117425)

  • 1. Comparison of small molecules and oligonucleotides that target a toxic, non-coding RNA.
    Costales MG; Rzuczek SG; Disney MD
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2605-9. PubMed ID: 27117425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
    Rzuczek SG; Colgan LA; Nakai Y; Cameron MD; Furling D; Yasuda R; Disney MD
    Nat Chem Biol; 2017 Feb; 13(2):188-193. PubMed ID: 27941760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.
    Wagner-Griffin S; Abe M; Benhamou RI; Angelbello AJ; Vishnu K; Chen JL; Childs-Disney JL; Disney MD
    J Med Chem; 2021 Jun; 64(12):8474-8485. PubMed ID: 34101465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Toxic RNA Catalyzes the Cellular Synthesis of Its Own Inhibitor, Shunting It to Endogenous Decay Pathways.
    Benhamou RI; Angelbello AJ; Wang ET; Disney MD
    Cell Chem Biol; 2020 Feb; 27(2):223-231.e4. PubMed ID: 31981476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
    Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
    J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity.
    Childs-Disney JL; Yildirim I; Park H; Lohman JR; Guan L; Tran T; Sarkar P; Schatz GC; Disney MD
    ACS Chem Biol; 2014 Feb; 9(2):538-550. PubMed ID: 24341895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Specific Cleavage of an RNA Repeat Expansion with a Dimeric Small Molecule Is Advantageous over Sequence-Specific Recognition by an Oligonucleotide.
    Benhamou RI; Angelbello AJ; Andrews RJ; Wang ET; Moss WN; Disney MD
    ACS Chem Biol; 2020 Feb; 15(2):485-493. PubMed ID: 31927948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.
    Costales MG; Suresh B; Vishnu K; Disney MD
    Cell Chem Biol; 2019 Aug; 26(8):1180-1186.e5. PubMed ID: 31130520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.
    Rzuczek SG; Southern MR; Disney MD
    ACS Chem Biol; 2015 Dec; 10(12):2706-15. PubMed ID: 26414664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR structures of small molecules bound to a model of a CUG RNA repeat expansion.
    Chen JL; Taghavi A; Frank AJ; Fountain MA; Choudhary S; Roy S; Childs-Disney JL; Disney MD
    Bioorg Med Chem Lett; 2024 Oct; 111():129888. PubMed ID: 39002937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule alteration of RNA sequence in cells and animals.
    Guan L; Luo Y; Ja WW; Disney MD
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2794-2796. PubMed ID: 29079470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocyclization of a Ligand Targeting a Toxic RNA Dramatically Improves Potency.
    Benhamou RI; Vezina-Dawod S; Choudhary S; Won Wang K; Meyer SM; Yildirim I; Disney MD
    Chembiochem; 2020 Nov; 21(22):3229-3233. PubMed ID: 32649032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.
    Yang B; Ming X; Cao C; Laing B; Yuan A; Porter MA; Hull-Ryde EA; Maddry J; Suto M; Janzen WP; Juliano RL
    Nucleic Acids Res; 2015 Feb; 43(4):1987-96. PubMed ID: 25662226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Modalities for Challenging Targets in Drug Discovery.
    Valeur E; Guéret SM; Adihou H; Gopalakrishnan R; Lemurell M; Waldmann H; Grossmann TN; Plowright AT
    Angew Chem Int Ed Engl; 2017 Aug; 56(35):10294-10323. PubMed ID: 28186380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods to enable the design of bioactive small molecules targeting RNA.
    Disney MD; Yildirim I; Childs-Disney JL
    Org Biomol Chem; 2014 Feb; 12(7):1029-39. PubMed ID: 24357181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10.
    Yang WY; Gao R; Southern M; Sarkar PS; Disney MD
    Nat Commun; 2016 Jun; 7():11647. PubMed ID: 27248057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Family of Small Molecules that Enhance the Intracellular Delivery and Pharmacological Effectiveness of Antisense and Splice Switching Oligonucleotides.
    Wang L; Ariyarathna Y; Ming X; Yang B; James LI; Kreda SM; Porter M; Janzen W; Juliano RL
    ACS Chem Biol; 2017 Aug; 12(8):1999-2007. PubMed ID: 28703575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule targeting of RNA structures in neurological disorders.
    Angelbello AJ; Chen JL; Disney MD
    Ann N Y Acad Sci; 2020 Jul; 1471(1):57-71. PubMed ID: 30964958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A toxic RNA catalyzes the in cellulo synthesis of its own inhibitor.
    Rzuczek SG; Park H; Disney MD
    Angew Chem Int Ed Engl; 2014 Oct; 53(41):10956-9. PubMed ID: 25164984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.